Ouabain modulates zymosan-induced peritonitis in mice

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Leite, Jacqueline Alves ^a   De Abreu Alves, Anne Kaliery ^b   Galvão, José Guilherme Marques ^b   Teixeira, Mariana Pires ^c   Cavalcante Silva, Luiz Henrique Agra ^b   Scavone, Cristoforo ^a   Morrot, Alexandre ^c   Rumjanek, Vivian Mary ^c   Rodrigues Mascarenhas, Sandra ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; OUABAIN; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; CELL DEATH; CELL SUBPOPULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EXTRAVASATION; FEMALE; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE COUNT; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONEUM EXUDATE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; ZYMOSAN-INDUCED PERITONITIS; ANIMAL; CELL SURVIVAL; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MACROPHAGE; METABOLISM; PERITONITIS; RANDOMIZATION;

MUS; STROPHANTHUS GRATUS;

ANIMALS; CELL SURVIVAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MACROPHAGES; MICE; OUABAIN; PERITONITIS; RANDOM ALLOCATION; ZYMOSAN;

EID: 84930652600     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/265798     Document Type: Article

References (48)

1. M. P. Blaustein, J. Zhang, L. Chen et al., "The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension", Hypertension, vol. 53, no. 2, pp. 291-298, 2009.
2. A. Y. Bagrov and J. I. Shapiro, "Endogenous digitalis: pathophysiologic roles and therapeutic applications", Nature Clinical Practice Nephrology, vol. 4, no. 7, pp. 378-392, 2008.
3. W. Schoner and G. Scheiner-Bobis, "Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth", American Journal of Physiology-Cell Physiology, vol. 293, no. 2, pp. 509-536, 2007.
4. J. Laredo, B. P. Hamilton, and J. M. Hamlyn, "Ouabain is secreted by bovine adrenocortical cells", Endocrinology, vol. 135, no. 2, pp. 794-797, 1994.
5. N. Bauer, J. Müller-Ehmsen, U. Krämer et al., "Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of β-blockade and angiotensin-converting enzyme inhibition", Hypertension, vol. 45, no. 5, pp. 1024-1028, 2005.
6. A. Goto, K. Yamada, H. Nagoshi, Y. Terano, and M. Omata, "Stress-induced elevation of ouabainlike compound in rat plasma and adrenal", Hypertension, vol. 26, no. 6, pp. 1173-1176, 1995.
7. W. Schoner, "Ouabain, a new steroid hormone of adrenal gland and hypothalamus", Experimental and Clinical Endocrinology & Diabetes, vol. 108, no. 7, pp. 449-454, 2000.
8. S. Rodrigues-Mascarenhas, A. D. S. de Oliveira, N. D. Amoedo, O. R. Affonso-Mitidieri, F. D. Rumjanek, and V. M. Rumjanek, "Modulation of the immune system by ouabain", Annals of the New York Academy of Sciences, vol. 1153, pp. 153-163, 2009.
9. B. Olej, N. F. dos Santos, L. Leal, and V. M. Rumjanek, "Ouabain induces apoptosis on PHA-activated lymphocytes", Bioscience Reports, vol. 18, no. 1, pp. 1-7, 1998.
10. V. L. G. de Moraes, B. Olej, L. de la Rocque, and V. M. Rumjanek, "Lack of sensitivity to ouabain in natural killer activity", The FASEB Jour nal, vol. 3, no. 12, pp. 2425-2429, 1989.
11. M. Szamel and K. Resch, "Inhibition of lymphocyte activation by ouabain. Interference with the early activation of membrane phospholipid metabolism", Biochimica et Biophysica Acta, vol. 647, no. 2, pp. 297-301, 1981.
12. 2+ entry", Life Sciences, vol. 73, no. 8, pp. 1037-1051, 2003.
13. S. Rodrigues-Mascarenhas, F. F. Bloise, J. Moscat, and V. M. Rumjanek, "Ouabain inhibits p38 activation in thymocytes", Cell Biology International, vol. 32, no. 10, pp. 1323-1328, 2008.
14. S. Rodrigues-Mascarenhas, N. F. D. Santos, and V. M. Rumjanek, "Synergistic effect between ouabain and glucocorticoids for the induction of thymic atrophy", Bioscience Reports, vol. 26, no. 2, pp. 159-169, 2006.
15. M. P. Teixeira and V. M. Rumjanek, "Ouabain affects the expression of activation markers, cytokine production, and endocytosis of human monocytes", Mediators of Inflammation, vol. 2014, Article ID 760368, 10 pages, 2014.
16. C. R. Nascimento, R. C. Valente, J. Echevarria-Lima et al., "The influence of Ouabain on human dendritic cells maturation", Mediators of Inflammation, vol. 2014, Article ID 494956, 15 pages, 2014.
17. P. L. Jacob, J. A. Leite, A. K. A. Alves et al., "Immunomodulatory activity of ouabain in Leishmania leishmania amazonensisinfected Swiss mice", Parasitology Research, vol. 112, no. 3, pp. 1313-1321, 2013.
18. D. I. B. De Vasconcelos, J. A. Leite, L. T. Carneiro et al., "Antiinflammatory and antinociceptive activity of ouabain in mice", Mediators of Inflammation, vol. 2011, Article ID 912925, 11 pages, 2011.
19. J. Bereta, M. C. Cohen, and M. Bereta, "Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-κB", FEBS Letters, vol. 377, no. 1, pp. 21-25, 1995.
20. G. Sowa and R. Przewłocki, "Ouabain enhances the lipopolysaccharide-induced nitric oxide production by rat peritoneal macrophages", Immunopharmacology, vol. 36, no. 1, pp. 95-100, 1997.
21. A. Matsumori, K. Ono, R. Nishio et al., "Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain", Circulation, vol. 96, no. 5, pp. 1501-1506, 1997.
22. A. Matsumori, K. Ono, R. Nishio, Y. Nose, and S. Sasayama, "Amlodipine inhibits the production of cytokines induced by ouabain", Cytokine, vol. 12, no. 3, pp. 294-297, 2000.
23. R. Medzhitov, "Origin and physiological roles of inflammation", Nature, vol. 454, no. 7203, pp. 428-435, 2008.
24. J. L. Cash, G. E. White, and D. R. Greaves, "Chapter 17. Zymosaninduced peritonitis as a simple experimental system for the study of inflammation", Methods in Enzymology, vol. 461, pp. 379-396, 2009.
25. M. N. Ajuebor, L. Virág, R. J. Flower, M. Perretti, and C. Szabó, "Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation", Immunology, vol. 95, no. 4, pp. 625-630, 1998.
26. N. S. Doherty, P. Poubelle, P. Borgeat, T. H. Beaver, G. L. Westrich, and N. L. Schrader, "Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2", Prostaglandins, vol. 30, no. 5, pp. 769-789, 1985.
27. M. N. Ajuebor, A. M. Das, L. Virág, R. J. Flower, C. Szabó, and M. Perretti, "Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10", Journal of Immunology, vol. 162, no. 3, pp. 1685-1691, 1999.
28. E. Kolaczkowska, R. Seljelid, and B. Plytycz, "Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice", Journal of Leukocyte Biology, vol. 69, no. 1, pp. 33-42, 2001.
29. E. Kolaczkowska, "Shedding light on vascular permeability during peritonitis: role of mast cell histamine versus macrophage cysteinyl leukotrienes", Inflammation Research, vol. 51, no. 11, pp. 519-521, 2002.
30. E. Kolaczkowska, S. Shahzidi, R. Seljelid, N. Van Rooijen, and B. Plytycz, "Early vascular permeability in murine experimental peritonitis is comediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes", Inflammation, vol. 26, no. 2, pp. 61-71, 2002.
31. E. Kolaczkowska, B. Arnold, and G. Opdenakker, "Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cellspecific production by mast cells, macrophages and neutrophils", Immunobiology, vol. 213, no. 2, pp. 109-124, 2008.
32. E. Kolaczkowska, A. Koziol, B. Plytycz, and B. Arnold, "Inflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis", Immunobiology, vol. 215, no. 6, pp. 492-504, 2010.
33. Y. Rong and M. Baudry, "Seizure activity results in a rapid induction of nuclear factor-κB in adult but not juvenile rat limbic structures", Journal of Neurochemistry, vol. 67, no. 2, pp. 662-668, 1996.
34. M. M. Bradford, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
35. T. Okazaki, V. S. Ilea, A. Okazaki, K. Wicher, R. E. Reisman, and C. E. Arbesman, "Inhibition of antigen induced histamine release by ouabain", The Journal of Allergy and Clinical Immunology, vol. 57, no. 5, pp. 454-462, 1976.
36. E. Ray and A. K. Samanta, "Receptor-mediated endocytosis of IL-8: a fluorescent microscopic evidence and implication of the process in ligand-induced biological response in human neutrophils", Cytokine, vol. 9, no. 8, pp. 587-596, 1997.
37. S. K. Manna, Y. Sreenivasan, and A. Sarkar, "Cardiac glycoside inhibits IL-8-induced biological responses by downregulating IL-8 receptors through altering membrane fluidity", Journal of Cellular Physiology, vol. 207, no. 1, pp. 195-207, 2006.
38. +-dependent amino acid transport", Biochemical Pharmacology, vol. 78, no. 9, pp. 1157-1166, 2009.
39. G. D. Brown, J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon, "Dectin-1 mediates the biological effects of β-glucans", The Journal of Experimental Medicine, vol. 197, no. 9, pp. 1119-1124, 2003.
40. V. le Cabec, S. Carréno, A. Moisand, C. Bordier, and I. Maridonneau-Parini, "Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively", The Journal of Immunology, vol. 169, no. 4, pp. 2003-2009, 2002.
41. A. Ozinsky, D. M. Underhill, J. D. Fontenot et al., "The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors", Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13766-13771, 2000.
42. M. N. Ajuebor, R. J. Flower, R. Hannon et al., "Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model", Journal of Leukocyte Biology, vol. 63, no. 1, pp. 108-116, 1998.
43. T. Kawai and S. Akira, "Signaling to NF-κB by Toll-like receptors", Trends in Molecular Medicine, vol. 13, no. 11, pp. 460-469, 2007.
44. Q. Yang, W. Huang, C. Jozwik et al., "Cardiac glycosides inhibit TNF-α/NF-βB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor", Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 27, pp. 9631-9636, 2005.
45. +-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes", Journal of Biological Chemistry, vol. 286, no. 36, pp. 31586-31597, 2011.
46. Z. Wang, M. Zheng, Z. Li et al., "Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition", Cancer Research, vol. 69, no. 16, pp. 6556-6564, 2009.
47. J. M. Hallett, A. E. Leitch, N. A. Riley, R. Duffin, C. Haslett, and A. G. Rossi, "Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation", Trends in Pharmacological Sciences, vol. 29, no. 5, pp. 250-257, 2008.
48. S. P. Hart, I. Dransfield, and A. G. Rossi, "Phagocytosis of apoptotic cells", Methods, vol. 44, no. 3, pp. 280-285, 2008.